Table 2.
Patients’ characteristics before and after ATO treatment
| Patient No. |
No. of RBC transfusions per week (mean units) |
platelet count (×109/L) |
Haemoglobin (g/dL) |
ANC (× 109/L) |
||||
|---|---|---|---|---|---|---|---|---|
| Before ATO therapy | After maximum response to ATO | Before ATO therapy | After maximum response to ATO | Before ATO therapy | After maximum responseto ATO | Before ATO therapy | After maximum response to ATO | |
| 1 |
1.8 |
Transfusion independence |
9 |
115 |
5.1 |
11.4 |
0.2 |
2.0 |
| 2 |
1.9 |
Transfusion independence |
11 |
73 |
5.3 |
8.6 |
0.1 |
0.8 |
| 3 |
2.3 |
Transfusion independence |
14 |
138 |
4.9 |
11.2 |
0.3 |
1.9 |
| 4 |
2.6 |
Transfusion independence |
9 |
107 |
6.1 |
12.3 |
0.2 |
2.2 |
| 5 | 1.9 | Transfusion independence | 5 | 67 | 5.7 | 8.8 | 0.2 | 0.9 |
RBC, red blood cells; ATO, arsenic trioxide; ANC, absolute neutrophil count.